Stock screenerAll disclosures →
EDGAR →
ABSI
Conviction 67HealthcareScan · Thu, Sep 24, 2026Absci Corp (ABSI) closed at $10.35 (+6.16%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 61, RS Rating 99, -11.0% from its 52-week high, +186.6% year to date. Sector: Healthcare · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
ABSI$10.35+6.16%
ResistanceSupportVol 14Insider buyVol MA14 4.23M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price10.35
Change+6.16%
Gap-2.00%
Rel volume1.45×
Avg volume3.96M
Avg $ vol36.77M
SMA 209.00
SMA 508.74
SMA 2005.66
Price vs 50+18.33%
Price vs 200+82.74%
MA stackbullish
50/200 cross—
Supertrendup · 8.33
RSI (14)61
MACD hist0.20
MACD crossbull · 4d
Stoch %K / %D74 / 71
ADX (14)24
+DI / −DI28 / 16
RSI divergence—
MACD divergence—
ATR %7.39%
ADR %7.09%
52w high11.62
52w low2.30
From 52w high-10.97%
Above 52w low+349.78%
New 52w highNo
SqueezeOff
Bollinger width33.04%
%B0.95
Donchian pos73.74%
Donchian high11.26
Donchian low7.79
AVWAP (52w high)9.49
vs AVWAP high+9.01%
AVWAP (52w low)7.03
vs AVWAP low+47.06%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d1.45×
Avg vol (14d)4.23M
Avg vol (20d)3.96M
Avg $ vol (20d)36.77M
Market cap1.78B
RS Rating99 / 99
RS 3m (vs SPY)-3.17%
RS 6m (vs SPY)+237.46%
RS line new highNo
Trend template7/8
Technical rank97.4
1 week+11.60%
1 month+7.42%
3 months+1.32%
6 months+254.28%
1 year+297.88%
YTD+186.57%
P/E-15.41
P/B7.21
P/S391.56
P/FCF-18.88
EPS-0.8400
Div yield—
ROE-46.80%
ROA-42.83%
Debt/Eq0.02
Current10.63
EV/EBITDA-15.39
Gross margin—
Net margin—
Rev growth-20.71%
EPS growth-11.71%
Price target14.25
Target upside37.75%
Analyst ratingBuy
Institutional92.97%
Ent. value1.67B
Revenue1.7M
Net income-33.21M
Gross profit—
Free cash flow-94.03M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out155.91M
Employees140
ListedThu, Jul 22, 2021
Free float108.6M
Float %72.2%
Short interest36.79M
Days to cover12.5d
Short volume61.4%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.21
Last surprise—
Setup gradeB
Conviction67 / 100
Pattern quality—
Tech rank97.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.64
Support7.90
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- ABSI Oct 2026 17.000 call (ABSI261016C00017000) interactive stock chartYahoo Finance UK · Wed, Sep 23, 2026
- Absci (NASDAQ:ABSI) Earns "Buy" Rating from Needham & Company LLCMarketBeat · Wed, Sep 23, 2026
- Needham reiterates Buy rating on Absci, $11 price targettradingview.com · Wed, Sep 23, 2026
- Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Knoweasternprogress.com · Tue, Sep 22, 2026
- Absci Corporation (ABSI) Stock Price, News, Quote & HistoryYahoo! Finance Canada · Tue, Sep 22, 2026
- Absci (ABSI) Stock Looks Expensive Against Its Book ValueYahoo Finance · Tue, Sep 22, 2026
- ABSI Q2 2026 Earnings: Loss Slightly Wider Than Estimated as Shares Edge Higher - Earnings Season Previewsiam.in · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in ABSI
No recent disclosed trades by Congress in ABSI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ABSI · open-market 1 buy
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Jonasson Zachariah CFO / CBO · Common Stock · 2026-08-31 | Tax | 8.32K | $72K | 2026-08-31 | 2026-09-01 |
Somaratne Ransi Mudalinayake CMO, Head of R&D · Stock Option (right to buy) · 2026-08-03 | Grant | 383K | — | 2026-08-03 | 2026-08-07 |
Somaratne Ransi Mudalinayake CMO, Head of R&D · Stock Option (right to buy) · 2026-03-03 | Grant | 650K | — | 2026-03-03 | 2026-08-07 |
Szela Mary T Director · Common Stock · 2026-06-30 | Buy | 12.9K | $149K | 2026-06-30 | 2026-07-06 |
McClain Sean Chief Executive Officer · Common Stock · 2026-06-24 | Tax | 59.9K | $603K | 2026-06-24 | 2026-06-26 |
VAN HOUTEN FRANS Director · Common Stock · 2026-06-04 | Grant | 10.1K | $0 | 2026-06-04 | 2026-06-08 |
Rabinovitsj Daniel A Director · Stock Option (right to buy) · 2026-06-04 | Grant | 39.8K | $0 | 2026-06-04 | 2026-06-08 |
Szela Mary T Director · Common Stock · 2026-06-04 | Grant | 10.1K | $0 | 2026-06-04 | 2026-06-08 |
Szela Mary T Director · Stock Option (right to buy) · 2026-06-04 | Grant | 39.8K | $0 | 2026-06-04 | 2026-06-08 |
Rabinovitsj Daniel A Director · Common Stock · 2026-06-04 | Grant | 10.1K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in ABSI · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.